Panbela Therapeutics, Inc. ( PBLA) - Stock Earnings
PBLA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
PBLA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -608000 USD | — USD |
| 2023Q2 | -5.8 million USD | — USD |
| 2023Q3 | -7.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PBLA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -4.8 million USD | 0 USD |
| 2021 | -10.1 million USD | 0 USD |
| 2022 | -34.9 million USD | -1.6 million USD |
| 2026 Est. | — | — |
PBLA
Price: $0.01
Earnings Per Share: -34.51 USD
P/E Ratio: -0.01
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.4 million
Market Capitalization: 53889